NR 565 Final Exam: Advanced Pharmacology
Fundamentals V4 Updated and Latest Questions and
Correct Answers with Rationale
1. Which cytochrome P450 enzyme is responsible for the metabolism of approximately 50%
of all clinically used drugs?
A. CYP2D6
B. CYP3A4
C. CYP1A2
D. CYP2C19
Ans: B
Rationale: CYP3A4 is the most abundant isoform in the human liver and intestine. It processes a wide
variety of therapeutic agents including statins and calcium channel blockers. When this enzyme is
inhibited, drug levels in the bloodstream can rise to toxic levels. Conversely, induction of this enzyme can
lead to therapeutic failure due to rapid clearance. Nurses must monitor for drug-drug interactions
involving this specific metabolic pathway. Understanding this enzyme’s role is critical for safe advanced
prescribing practices.
2. Which phase of drug metabolism primarily involves conjugation reactions to make a drug
more polar for excretion?
A. Phase I
B. Phase III
C. Phase II
D. First-pass effect
Ans: C
,Rationale: Phase II metabolism involves the attachment of an endogenous molecule to the drug. This
process typically includes glucuronidation, acetylation, or sulfation to increase water solubility. Most
metabolites produced in this phase are pharmacologically inactive and ready for renal clearance. In
contrast, Phase I reactions focus on oxidation, reduction, or hydrolysis. Some drugs bypass Phase I and go
directly to conjugation. Clinicians must consider liver health as it significantly impacts these chemical
transformations.
3. What is the primary mechanism of action for ACE inhibitors in the management of
hypertension?
A. Blocking calcium influx into smooth muscle cells
B. Antagonizing beta-1 receptors in the heart
C. Inhibiting the conversion of Angiotensin I to Angiotensin II
D. Increasing sodium reabsorption in the distal tubule
Ans: C
Rationale: ACE inhibitors prevent the formation of Angiotensin II, which is a potent vasoconstrictor. This
reduction leads to systemic vasodilation and decreased peripheral resistance. It also decreases the
secretion of aldosterone, promoting sodium and water excretion. These medications are particularly
beneficial for patients with diabetes and chronic kidney disease. A common side effect is a persistent dry
cough caused by bradykinin accumulation. Monitoring potassium levels is essential as these drugs can
cause hyperkalemia.
,4. A patient with a history of asthma is diagnosed with hypertension; which class of
antihypertensives should be avoided?
A. Calcium channel blockers
B. Thiazide diuretics
C. Non-selective beta-blockers
D. ARB blockers
Ans: C
Rationale: Non-selective beta-blockers like propranolol block both beta-1 and beta-2 receptors. Blocking
beta-2 receptors in the lungs can lead to bronchoconstriction and airway narrowing. This effect is
dangerous for patients with asthma or COPD. Selective beta-1 blockers are generally preferred if a beta-
blocker is strictly necessary. Prescribers should always assess pulmonary history before initiating
therapy with these agents. Alternative classes like CCBs or ACEIs are usually safer for hypertensive
asthmatics.
, 5. Which laboratory value is most critical to monitor for a patient taking a HMG-CoA
reductase inhibitor (Statin)?
A. Serum Creatinine
B. Thyroid Stimulating Hormone (TSH)
C. Alanine Aminotransferase (ALT)
D. Complete Blood Count (CBC)
Ans: C
Rationale: Statins can cause hepatotoxicity, making baseline and periodic liver function tests important.
ALT is a specific marker for liver cell damage that must be monitored. Patients should also be educated to
report unexplained muscle pain or weakness. This could indicate rhabdomyolysis, a rare but severe side
effect affecting muscles. Creatine kinase levels may be checked if muscle symptoms occur during
treatment. Proper monitoring ensures the benefits of lipid lowering outweigh the systemic risks.
6. What is the primary black box warning associated with all antidepressant medications?
A. Increased risk of hypertensive crisis
B. Sudden cardiac death from QT prolongation
C. Risk of suicidal ideation in children and young adults
D. Permanent tardive dyskinesia
Ans: C
Fundamentals V4 Updated and Latest Questions and
Correct Answers with Rationale
1. Which cytochrome P450 enzyme is responsible for the metabolism of approximately 50%
of all clinically used drugs?
A. CYP2D6
B. CYP3A4
C. CYP1A2
D. CYP2C19
Ans: B
Rationale: CYP3A4 is the most abundant isoform in the human liver and intestine. It processes a wide
variety of therapeutic agents including statins and calcium channel blockers. When this enzyme is
inhibited, drug levels in the bloodstream can rise to toxic levels. Conversely, induction of this enzyme can
lead to therapeutic failure due to rapid clearance. Nurses must monitor for drug-drug interactions
involving this specific metabolic pathway. Understanding this enzyme’s role is critical for safe advanced
prescribing practices.
2. Which phase of drug metabolism primarily involves conjugation reactions to make a drug
more polar for excretion?
A. Phase I
B. Phase III
C. Phase II
D. First-pass effect
Ans: C
,Rationale: Phase II metabolism involves the attachment of an endogenous molecule to the drug. This
process typically includes glucuronidation, acetylation, or sulfation to increase water solubility. Most
metabolites produced in this phase are pharmacologically inactive and ready for renal clearance. In
contrast, Phase I reactions focus on oxidation, reduction, or hydrolysis. Some drugs bypass Phase I and go
directly to conjugation. Clinicians must consider liver health as it significantly impacts these chemical
transformations.
3. What is the primary mechanism of action for ACE inhibitors in the management of
hypertension?
A. Blocking calcium influx into smooth muscle cells
B. Antagonizing beta-1 receptors in the heart
C. Inhibiting the conversion of Angiotensin I to Angiotensin II
D. Increasing sodium reabsorption in the distal tubule
Ans: C
Rationale: ACE inhibitors prevent the formation of Angiotensin II, which is a potent vasoconstrictor. This
reduction leads to systemic vasodilation and decreased peripheral resistance. It also decreases the
secretion of aldosterone, promoting sodium and water excretion. These medications are particularly
beneficial for patients with diabetes and chronic kidney disease. A common side effect is a persistent dry
cough caused by bradykinin accumulation. Monitoring potassium levels is essential as these drugs can
cause hyperkalemia.
,4. A patient with a history of asthma is diagnosed with hypertension; which class of
antihypertensives should be avoided?
A. Calcium channel blockers
B. Thiazide diuretics
C. Non-selective beta-blockers
D. ARB blockers
Ans: C
Rationale: Non-selective beta-blockers like propranolol block both beta-1 and beta-2 receptors. Blocking
beta-2 receptors in the lungs can lead to bronchoconstriction and airway narrowing. This effect is
dangerous for patients with asthma or COPD. Selective beta-1 blockers are generally preferred if a beta-
blocker is strictly necessary. Prescribers should always assess pulmonary history before initiating
therapy with these agents. Alternative classes like CCBs or ACEIs are usually safer for hypertensive
asthmatics.
, 5. Which laboratory value is most critical to monitor for a patient taking a HMG-CoA
reductase inhibitor (Statin)?
A. Serum Creatinine
B. Thyroid Stimulating Hormone (TSH)
C. Alanine Aminotransferase (ALT)
D. Complete Blood Count (CBC)
Ans: C
Rationale: Statins can cause hepatotoxicity, making baseline and periodic liver function tests important.
ALT is a specific marker for liver cell damage that must be monitored. Patients should also be educated to
report unexplained muscle pain or weakness. This could indicate rhabdomyolysis, a rare but severe side
effect affecting muscles. Creatine kinase levels may be checked if muscle symptoms occur during
treatment. Proper monitoring ensures the benefits of lipid lowering outweigh the systemic risks.
6. What is the primary black box warning associated with all antidepressant medications?
A. Increased risk of hypertensive crisis
B. Sudden cardiac death from QT prolongation
C. Risk of suicidal ideation in children and young adults
D. Permanent tardive dyskinesia
Ans: C
